Insulet Corp PODD

$141.90 -0.74 (-0.52%)

Valuation

Market cap
9,892,653,000
Revenue TTM
$2,708,100,000
Net income TTM
$247,100,000
PE ratio
24.18
Forward PE
21.80
Profit margin
9.12%
Debt to equity
0.67

Trading

Volume
1,046,200
Avg volume
1,650,320
Day's range
$140.81 – $146.63
Shares out
69,354,000
Stochastic %K
64%
Beta
1.11
Analysts
Strong Sell
Price target
$166.04

Price

Company profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values throu...

Show more

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Industry
Medical Devices
Sector
Healthcare
Phone
978 600 7000
Website
https://www.insulet.com
Address
100 Nagog Park, Acton, United States

Latest news

Stocktwits

razor4 Oct 20, 6:22 PM
$PODD Stuck....need to cross 150!
0 replies
EquityVortexx Oct 20, 9:01 AM
$PATH $PODD SpaceX may challenge the wireless status quo, yet ground networks still have strengths in busy areas. Could hybrid coverage be the winning model?
0 replies
Butters33 Oct 19, 9:34 AM
$PODD - Built a large position in PODD over the last few months. The chart alone gives me hope. Plan to hold for the next 3 years.
1 replies
anvesti Oct 15, 7:41 PM
Anvesti opened a long position $PODD · Entry $138.53 Model: ml_model_v3 · Score: 82.6
0 replies
bulltrades1234 Oct 15, 2:07 PM
$PODD how is this stock green in a mixture of red lol 😂
0 replies
bulltrades1234 Oct 14, 2:38 PM
$PODD 3 more weeks to earnings let’s see what this stock has in store
0 replies
Quantumup Oct 12, 12:15 PM
Jefferies🏁 $BBNX Buy-$30 and said: We see a strong catalyst pathway for BBNX, including the Mint patch pump launch, DME/ Pharmacy transition impact on growth & margins in '27+ 8x share gains, supported by our survey and channel checks. $PODD TNDM $DXCM ABT MDT Here's what Jefferies went on to say in its initiation report: https://x.com/Quantumup1/status/2109618735627604459?s=20
0 replies
bulltrades1234 Oct 9, 3:59 PM
$PODD it’s getting really frustrating to hold this stock tbh who else with me on that
1 replies